Scopus: Exploring Benzo[b][1,4]Thiazine Derivatives: Multitarget Inhibition, Structure–Activity Relationship, Molecular Docking, and ADMET Analysis
dc.contributor.author | Alishba | |
dc.contributor.author | Ali, I. | |
dc.contributor.author | Hameed, S. | |
dc.contributor.author | Khan, K.M. | |
dc.contributor.author | Salar, U. | |
dc.contributor.author | Taha, M. | |
dc.contributor.author | Sadeghian, N. | |
dc.contributor.author | Taslimi, P. | |
dc.contributor.author | Tuzun, B. | |
dc.contributor.author | Özerkan, D. | |
dc.contributor.author | Dedeakayogullari, H. | |
dc.contributor.author | Ulukaya, E. | |
dc.date.accessioned | 2024-10-21T06:52:06Z | |
dc.date.available | 2024-10-21T06:52:06Z | |
dc.date.issued | 2024 | |
dc.description.abstract | A series of benzothiazine derivatives (1–17) were synthesized via an intermolecular cyclocondensation reaction involving 2-aminothiophenol (i) and substituted phenacyl bromide (ii). Structural elucidation of these synthetic derivatives utilized EI–MS, HR-EIMS, 1H NMR, and 13C NMR spectroscopic techniques. The synthesized analogs were evaluated against key enzyme targets (acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α-glucosidase (α-Glu)) and tested for cytotoxicity against various cancer cell lines. Six compounds were selected based on their inhibition profiles, exhibiting significant inhibitory potential against enzymes. In silico studies corroborated the observed inhibitory activities, aligning closely with experimental outcomes. Additionally, an ADME/T study provided insights into pharmacokinetic and safety profiles, identifying promising candidates for future drug development efforts. | |
dc.identifier | 10.1002/slct.202404087 | |
dc.identifier.doi | 10.1002/slct.202404087 | |
dc.identifier.issn | 23656549 | |
dc.identifier.issue | 38 | |
dc.identifier.scopus | 2-s2.0-85206248072 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12597/33671 | |
dc.identifier.volume | 9 | |
dc.language.iso | en | |
dc.publisher | John Wiley and Sons Inc | |
dc.relation.ispartof | ChemistrySelect | |
dc.relation.ispartofseries | ChemistrySelect | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | ADME/T, Alzheimer's disease, Cancer, Diabetes, Synthesis | |
dc.title | Exploring Benzo[b][1,4]Thiazine Derivatives: Multitarget Inhibition, Structure–Activity Relationship, Molecular Docking, and ADMET Analysis | |
dc.type | article | |
dspace.entity.type | Scopus | |
oaire.citation.issue | 38 | |
oaire.citation.volume | 9 | |
person.affiliation.name | University of Karachi | |
person.affiliation.name | University of Karachi | |
person.affiliation.name | University of Karachi | |
person.affiliation.name | University of Karachi | |
person.affiliation.name | University of Karachi | |
person.affiliation.name | Imam Abdulrahman Bin Faisal University | |
person.affiliation.name | Bartin Üniversitesi | |
person.affiliation.name | Bartin Üniversitesi | |
person.affiliation.name | Cumhuriyet Üniversitesi | |
person.affiliation.name | Kastamonu University | |
person.affiliation.name | Biruni Üniversitesi | |
person.affiliation.name | Istanbul Üniversitesi | |
person.identifier.orcid | 0000-0001-8337-4021 | |
person.identifier.scopus-author-id | 57211030862 | |
person.identifier.scopus-author-id | 57214833586 | |
person.identifier.scopus-author-id | 57210599649 | |
person.identifier.scopus-author-id | 57189389857 | |
person.identifier.scopus-author-id | 56600650200 | |
person.identifier.scopus-author-id | 25825585300 | |
person.identifier.scopus-author-id | 57218843072 | |
person.identifier.scopus-author-id | 56658628800 | |
person.identifier.scopus-author-id | 56699974000 | |
person.identifier.scopus-author-id | 56805133700 | |
person.identifier.scopus-author-id | 57191334242 | |
person.identifier.scopus-author-id | 6602927353 |